Entering text into the input field will update the search result below

Natera, Inc. (NTRA) CEO Steve Chapman on Q3 2021 Results - Earnings Call Transcript

Nov. 04, 2021 11:54 PM ETNatera, Inc. (NTRA)
SA Transcripts profile picture
SA Transcripts

Natera, Inc. (NASDAQ:NTRA) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET

Company Participants

Michael Brophy - Chief Financial Officer

Steve Chapman - Chief Executive Officer

Solomon Moshkevich - General Manager of Oncology & Transplant

Conference Call Participants

Tejas Savant - Morgan Stanley

Tycho Peterson - JPMorgan

Puneet Souda - SVB Leerink

Catherine Schulte - Baird

Alex Nowak - Craig-Hallum Capital Group

Mark Massaro - BTIG


Welcome to Natera's 2021 Third Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, November 4, 2021.

I would now like to turn the conference call over to Michael Brophy, Chief Financial Officer. Please go ahead.

Michael Brophy

Thanks, operator. Good afternoon. Thank you for joining our conference call to discuss the results of our third quarter of 2021. On the line is Steve Chapman, our CEO; Paul Billings, our Chief Medical Officer; and Solomon Moshkevich, General Manager of Oncology. Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of the call will also be available at investor.natera.com.

During the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our operational and financial outlook and projections; our assumptions for that outlook, market size, partnerships, clinical studies, opportunities and strategies; and expectations for various current and future products, including product capabilities, expected release dates, reimbursement coverage and related effects on our financial and operating results. We caution you that such statements reflect our best judgment based on factors currently known to us, and that actual events or results could differ materially. Please refer to documents we file from time to time with the SEC, including our most recent Form 10-K or 10-Q and the Form 8-K filed with today's press release. Those documents

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.